Cargando…

Trends in Prices of Popular Brand-Name Prescription Drugs in the United States

IMPORTANCE: High and continually increasing pharmaceutical drug spending is a major health and health policy concern in the United States. OBJECTIVE: To demonstrate trends in prices among popular brand-name prescription drugs. DESIGN, SETTING, AND PARTICIPANTS: This economic evaluation of drug price...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wineinger, Nathan E., Zhang, Yunyue, Topol, Eric J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547085/ https://www.ncbi.nlm.nih.gov/pubmed/31150077 http://dx.doi.org/10.1001/jamanetworkopen.2019.4791

Ejemplares similares

Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs
por: Rome, Benjamin N., et al.
Publicado: (2021)

Estimates of Medicaid and Non-Medicaid Net Prices of Top-Selling Brand-name Drugs Incorporating Best Price Rebates, 2015 to 2019
por: Clemans-Cope, Lisa, et al.
Publicado: (2023)

Off-patent drugs at brand-name prices: a puzzle for policymakers
por: Tallapragada, Naren P.
Publicado: (2016)

What’s in a Name? Use of Brand versus Generic Drug Names in United States Outpatient Practice
por: Steinman, Michael A., et al.
Publicado: (2007)

Product-Line Extensions and Pricing Strategies of Brand-Name Drugs Facing Patent Expiration
por: Hong, Song Hee, et al.
Publicado: (2005)

Trends in Use and Expenditures for Brand-name Statins After Introduction of Generic Statins in the US, 2002-2018
por: Lin, Shuo-yu, et al.
Publicado: (2021)

Competition and price among brand-name drugs in the same class: A systematic review of the evidence
por: Sarpatwari, Ameet, et al.
Publicado: (2019)

Patient socioeconomic determinants of the choice of generic versus brand name drugs in the context of a reference price system: evidence from Belgian prescription data
por: Farfan-Portet, Maria-Isabel, et al.
Publicado: (2012)

Spending and Out-of-Pocket Prices for Brand-Name Drugs Among Commercially Insured Individuals in Massachusetts, 2015-2017
por: Aaron, Micah B., et al.
Publicado: (2021)

Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending
por: WOUTERS, OLIVIER J., et al.
Publicado: (2017)

Trends in Within-Class Changes in US Average Wholesale Prices for Brand-Name Medications for Common Conditions From 2015 to 2020
por: Liu, Patrick, et al.
Publicado: (2021)

Comparative Effectiveness of Generic vs Brand-Name Levothyroxine in Achieving Normal Thyrotropin Levels
por: Brito, Juan P., et al.
Publicado: (2020)

Brand Name and Generic Proton Pump Inhibitor Prescriptions in the United States: Insights from the National Ambulatory Medical Care Survey (2006–2010)
por: Gawron, Andrew J., et al.
Publicado: (2015)

Characteristics of State Legislation Addressing Prescription Drug Price Increases in the United States, 2020
por: Shahriar, Arman A., et al.
Publicado: (2021)

Factors Associated With Prescriptions for Branded Medications in the Medicare Part D Program
por: Socal, Mariana P., et al.
Publicado: (2021)

Projected spending for brand-name drugs in English primary care given US prices: a cross-sectional study
por: Liu, Michael, et al.
Publicado: (2020)

Trends in Prescription Analgesic Use Among Adults With Musculoskeletal Conditions in the United States, 1999-2016
por: Stokes, Andrew, et al.
Publicado: (2019)

Brand Suicide? Memory and Liking of Negative Brand Names
por: Guest, Duncan, et al.
Publicado: (2016)

Trends in Out-of-Pocket Costs for Naloxone by Drug Brand and Payer in the US, 2010-2018
por: Peet, Evan D., et al.
Publicado: (2022)

Brand Name Versus Generic?
por: Aungaroon, Gewalin
Publicado: (2023)

The concept of: Generic drugs and patented drugs vs. brand name drugs and non-proprietary (generic) name drugs
por: Thakkar, Karan B., et al.
Publicado: (2013)

Letter frequency analysis of proprietary prescription drug names in the United States: Minding the Zs and Qs
por: Carico, Ron, et al.
Publicado: (2022)

Association of Branded Prescription Drug Rebate Size and Patient Out-of-Pocket Costs in a Nationally Representative Sample, 2007-2018
por: Yeung, Kai, et al.
Publicado: (2021)

Characteristics and Price Increases Among Sole-Source, Off-Patent Drugs in the United States, 2008 to 2018
por: Alpern, Jonathan D., et al.
Publicado: (2020)

Brands, networks, communities: How brand names are wired in the mind
por: Kovács, László, et al.
Publicado: (2022)

Are brand names special words? Letter visual‐similarity affects the identification of brand names, but not common words
por: Perea, Manuel, et al.
Publicado: (2022)

Generic versus brand-name drugs used in cardiovascular diseases
por: Manzoli, Lamberto, et al.
Publicado: (2015)

Generics versus brand-named drugs for glaucoma: the debate continues
por: Bhartiya, Shibal, et al.
Publicado: (2020)

605. Factors Underlying Antifungal Price Trends in the United States
por: Thomas, Christine, et al.
Publicado: (2020)

Not as bad as you think: a comparison of the nutrient content of best price and brand name food products in Switzerland
por: Khalatbari-Soltani, Saman, et al.
Publicado: (2016)

Decreasing utilization and increasing prices of brand-name oral contraceptive pills: Implications to societal costs and market competition
por: Zhang, James X.
Publicado: (2020)

An ERP-study of brand and no-name products
por: Thomas, Anika, et al.
Publicado: (2013)

The influence of Medicare Part D on the list pricing of brand drugs
por: Ippolito, Benedic N., et al.
Publicado: (2023)

Association study between drug prescriptions and Alzheimer’s disease claims in a commercial insurance database
por: Hu, Eric, et al.
Publicado: (2023)

The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?
por: Sarpatwari, Ameet, et al.
Publicado: (2016)

Elemental impurities analysis in name-brand and generic omeprazole drug samples
por: Pinheiro, Fernanda C., et al.
Publicado: (2020)

Hello, my name is awesome: how to create brand names that stick
por: Watkins, Alexandra
Publicado: (2019)

A framework for smartphone-enabled, patient-generated health data analysis
por: Gollamudi, Shreya S., et al.
Publicado: (2016)

Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States
por: Chen, Qiushi, et al.
Publicado: (2019)

Prescription stimulant brand name recognition among a national sample of 10‐ to 18‐year‐old youth
por: Cottler, Linda B., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e1igl1ihdhsvt6kouv4um5oq3s